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Abstract
Background: Deranged liver is a well-recognized feature of dengue infection, often
demonstrated by coagulopathy and mild to moderate increase in transaminase
levels although jaundice and fulminant hepatic failure are generally uncommon.
Objective: This study aimed to evaluate the hepatic effect of dengue fever amongst
Sudanese patients. Materials and Methods: A cross-sectional descriptive study
recruited in Port Sudan teaching hospital in the period from February 2013 to June
2014. 334 cases of dengue along with 101 cases of control were enrolled. The rapid
immune chromatographies test was used to confirm positive dengue cases and
WHO criteria were used for classifying the dengue severity. Prothrombin time (PT),
partial thromboplastin time (PTT), fibrinogen level (FB), platelet count (PLT), aspartate
aminotransferase (AST), alanine aminotransferase (ALT) and C-reactive protein (CRP)
were all measured. Results: PT, PTT, and FB were found to be significantly higher in
the infected cohort when compared to the controls (P < 0.0001). PT was prolonged in
9%, PTT was prolonged in 12.6% and shortened by 5.4% of the patients, whereas
hypofibrinogenemia in 18.3% and hyperfibrinogenemia in 67.4% of the patients.
Bleedingwas seen in 10.5% of patients and thrombocytopenia was detected in 83.5%
of patients. Out of 334 patients, 101 (30.2%) had abnormal coagulation results. Of 101
patients, 72 were subjected mixing studies for PT and PTT that revealed deficiencies
in factors VIII (35%), IX (10%), V (10%), X (19%), and XII (14%). 43.6% patients had
elevated AST and 21.8% had elevated ALT. Conclusion: This study demonstrated that
hepatic dysfunction may be attributed to dengue virus infection which evident by
prolongation in PT and PTT as well as hypofibrinogenemia and factor deficiencies.
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1. Introduction
Dengue virus has recently become amajor public health concern, particularly in tropical
and subtropical countries, predominantly in urban and periurban areas [1]. The inci-
dence of dengue has grown dramatically over the world in recent decades. Over 2.5
billion people of the world’s population are now at risk from dengue [2]. WHO currently
estimated there may be 50-100 million dengue infections worldwide every year [2].
The resurgence of dengue has been observed in Port Sudan, Red Sea State, Sudan and
dengue outbreak have been frequently reported from different part of the State in both
urban and rural populations [3, 4]. Dengue virus (DENV) is a mosquito-borne Flavivirus
that is transmitted by mosquitoes such as Aedes aegypti or Aedes albopictus. Based on
the antigenic difference, DENV can be divided into five different serotypes, DENV 1 – 5.
The most serious manifestations of the infection are dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS) [5, 6]. The degree of liver dysfunction varies from
mild injury with an elevation of aminotransferase to even fulminant hepatic failure
[7, 8]. Hepatic dysfunction in dengue infection may be attributed to direct viral effect
on liver cells or as a consequence of dysregulation host immune responses against the
virus [7]. Jaundice in dengue infection has been associated with fulminant liver failure
and by itself is a poor prognostic factor [9]. However, there is still not much work
was done in the studied area regarding the liver changes of dengue infection. This
study was conducted to evaluate the variations of liver dysfunction by measuring the
level of the liver enzymes, prothrombin time (PT), partial thromboplastin time (PTT),
fibrinogen (FB) level and coagulation mixing studies. The significance of this study
is the importance of measuring the liver enzymes in the patients with dengue virus
infection.
2. Materials and Methods
A cross-sectional descriptive study was conducted in the period from February 2013 to
June 2014 at Port Sudan teaching hospital, Red Sea State, Sudan. Three hundred thirty-
four patients who were positive for dengue infection attending the hospital and 101
healthy controls were enrolled in the study.
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2.1. Inclusion and Exclusion Criteria
All patients with clinical features and serologically positive dengue infection were
included. The sample taken before hemostatic agents and blood transfusion admin-
istrated to the patients. The exclusion criteria include patients with serologically neg-
ative dengue or any other disease.
2.2. Study Sample
The blood samples were collected from all of the studied population. 3 ml of blood was
transferred to tri- sodium citrate buffer tube, 3 ml in plain containers and 3 ml treated
with tri-potassium ethylene diamine tetra acetic acid (K3EDTA). The samples under
standard laboratory temperature were processed to obtain serum and platelet poor
plasma by using a centrifugation. The analysis was performed by expert technologists.
Chemical tests: aspartate aminotransferase (AST), alanine aminotransferase (ALT),
and C-reactive protein (CRP) were examined within 2 hours of collection and deter-
mined by NycoCard® method using NycoCard® READER II (SN 67498, Axis- Shield PoC
AS, Oslo, Norway). Chemical tests were determined by (BioSystems Chemicals S. A
Costa Brava, Barcelona (Spain), expiry at 8/2015).
Hematological tests: Platelet counts were done using an automated hematology
analyzer (Sysmex KX-21N, B 7151, and MF 9/2008 Japan). Coagulation tests: PT, PTT and
FB were examined within 4 hours of collection using a semi-automated blood coagula-
tion analyzer (bio bas-1 manufactured by RAL for SPINREACT, SN 536, Spain-European
Community). Coagulation tests were determined by (Biomed diagnostic reagent, Ger-
many).
2.3. Definition of Dengue
Dengue is a disease caused by any one of five closely related dengue viruses (DENV-1,
-2, -3, -4, and -5) [6]. The clinical spectrum of dengue classified to DF and DHF (DHF I,
DHF II, DHF III and DHF IV) [10].
2.4. Criteria for Dengue Severity
Patients were classified as dengue fever, dengue hemorrhagic fever or dengue shock
syndrome according to WHO guidelines. The laboratory diagnosis of dengue was
established by the demonstration of IgM and IgG immune chromatography Rapid
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diagnostic test (RDT) (BioTracer/BioFocus, REF: 17112, Exp.12/2015, Korea), sensitivity
95.6 and specificity 96.
2.5. Statistical Analysis
Laboratory data of PLT, coagulation tests, and chemical investigations of patients with
DF, DHF were statistically tested by Independent-sample t test, Correlation, and Pear-
son Chi-square test, whichever was appropriate. A P. value less than 0.05 were con-
sidered statistically significant. The Statistical Package for Social Sciences (SPSS 20.0
version, IBN. Chicago, USA) was used for data analysis.
2.6. Ethical Considerations
This study was approved by the regional Ethical Review Committee (ERC), written
informed consent was obtained from all of the patients.
3. Results
The total number of the confirmed dengue patients was 334. Of the 334 patients, (217)
65% were males and (117) 35% were female. In the control group, (64) 63.4% were
males and (37) 36.6% were females. Minimum age of the patient was 3 years and
maximum age was 80 years with the mean age being 30±15. Minimum age of control
was 6 years and maximum age was 76 years with mean age 22±6.
The clinical findings have been summarized in Table 1. The clinical demographic
manifestations of the studied group were fever (334,100%), headache (282, 84.4%),
joint pain (262, 78.2%), backache (198, 59.3%), myalgia (156, 46.7%), retro-orbital pain
(69, 20.7%), and rash (28, 8.4%). According to the WHO classification system most
cases of the current study were dengue fever; followed by dengue hemorrhagic fever
I (Table 1).
All of the patients (334) presented were screened for PT, PTT and FB. The differ-
ence between the patient group and the control group was found to be significant
in prothrombin time, partial thromboplastin time, and fibrinogen level (P < 0.0001).
Prothrombin time, partial thromboplastin time, and fibrinogen levels were higher in
the patient group than in the control (Table 2). Thrombocytopenia was observed in
(279/334; 83.5%) of the patients. 234 (81%) presented in DF cases and 45 (100%)
presented in DHF cases. Bleeding manifestations were observed higher in DHF than
in DF patients (P < 0.0001). Bleeding was recorded in 35 (10.5%) cases of all dengue
patients (Table 3). Bleeding manifestations included hematuria in 19 (54.3%) cases,
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hematemesis in 1 (2.9%), hemoptysis in 1 (2.9%), epistaxis in 5 (14.2%) cases, and
gum bleeds in 9 (25.7%) cases.
PT was prolonged in 30 (9.0%) of the patients and normal in 304 (91%). PTT was
prolonged in 42 (12.6%) of patients, shortened in 18 (5.4%) of patients, and normal
in 274 (82%) of the patients. 8 (2.4%) patients had prolonged PT and PTT together.
The reduced fibrinogen level was noted in 61 (18.3%), 48 (14.4%) patients had high
fibrinogen level, and 225 (67.4%) was normal fibrinogen level (Table 3). Out of 61
patients with reduced fibrinogen 29 patients were associated with prolonged PT and
PTT. There was a positive correlation between short PTT and high fibrinogen (P <
0.0003); this relationship could be interpreted as an acute phase response situation.
Out of 334 patients’ positive dengue infection, 101 (30.2%) had abnormal coagu-
lation results. 81 (80.2%) patients with DF and 20 (19.8%) patients with DHF were
screened for special parameters such as AST, ALT, and CRP (Table 4). The transaminase
liver enzymes were relatively higher in DHF than DF. 44 (43.6%) patients had an
elevated level AST, while 22 (21.8%) patients had an elevated level ALT. C-reactive
protein was significantly higher in DHF 20 (100%) patients than the DF 65 (80.3%)
patients (Table 5). Of 101 patients 72 Correction tests for PT and PTT were performed.
The corrected results indicate a deficient factor. 72 Mixing experimental studies for
PT and PTT revealed deficiencies in factors VIII 25 (35%), IX, 7 (10%), V 7 (10%), X
14 (19%), II 9 (12%), and XII 10 (14%). This suggests the dysfunction of liver cells in
respect to the decreased synthesis of these factors.
4. Discussion
Deranged liver function in dengue infection can be a result of the direct effect of
the virus on liver cells or the unregulated host immune response against the virus.
Hepatic dysfunction in dengue infection is often demonstrated by mild to moderate
raising in transaminase enzyme levels [11]. Abnormal liver tests are generally present
in the first days of clinical infection and peak during the second week of illness [12].
Aminotransferase levels are useful in predicting the occurrence of hepatic dysfunction
and spontaneous bleeding. Liver enzyme elevation is a common feature in dengue
infection [13]. Wang and Shyn reported that AST abnormality was predominantly high
as compared to ALT; 91% and 72% respectively [14]. However, in this study, AST levels
were equal to or greater than those of ALT levels in most infected patients, a finding
that has also been reported earlier [5, 15]. Abnormal liver enzymes in dengue infection
have been reported also by various authors and the levels varies from 36.4% - 96%
[16]. Our study observed elevated AST in 43.2% of DF, 45% of DHF and elevated ALT in
21% of DF, 25% of DHF. The liver enzymes were significantly more common in DHF/DSS
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Characteristics Patients (n = 334) Control (n = 101) P. value
Age
(mean ± SD) 30 ± 15 22 ± 6 0.0001
(Range) 3 – 80 y 6 – 76 y
Sex
Male 217 (65%) 64 (63.4%) 0.7262
Female 117 (35%) 37 (36.6%)
Clinical diagnosis
Dengue fever 289 (86.5%)
DHF grade I 31 (9.3%)
DHF grade II 12 (3.6%)
DHF grade III 2 (0.6%)
Clinical manifestations
Rash (Purpura) 28 (8.4%) 0.0030
Fever 334 (100%) 0.0001
Joint pain 262 (78.4%) 0.0001
Backache 198 (59.3%) 0.0001
Headache 282 (84.4%) 0.0001
Myalgia 156 (46.7%) 0.0001
Retro-orbital pain 69 (20.7%) 0.0001





Bleeding gums 9 (2.7%)
T 1: The epidemiological and clinical feature of the studied population.
when compared to DF, a finding similar to other studies[17, 18]. Souza et al reported in
large studies in Brazil, out of 1585 dengue cases, raised AST and ALT in 63.4% and 45%
of patients respectively [19]. Jagadishkumar et al suggested that the higher incidence
of more than 10-fold rise in liver enzymes was observed in children in comparison to
adult. This may be due to that children are at higher risk of hepatic involvement [11].
AST levels rise more than ALT in case of dengue and this may be due to myositis,
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PT second 14.1± 2.1 13.3 ± 1.6 13.8 13.5 10–20.4 10-16.5 0.0001
PTT second 33.5 ± 9.7 29.6 ± 4.5 32.4 28.9 15–80.7 20-39 0.0001





T 2: The difference between test and control in studied parameters.
Parameter DFn = 289 DHF n = 45 P. value
Thrombocytopenia 234 (81%) 45 (100%) 0.0001
Bleeding manifest 10 (3.5%) 25 (55.6%) 0.0001
Prolong PT 27 (9.3%) 3 (6.7%) 0.0001
Prolong PTT 32 (11.1%) 10 (22.2%) 0.0001
Hypofibrinogenemia 48 (16.6%) 13 (28.9%) 0.0001
Hyperfibrinogenemia 40 (13.8%) 8 (17.8%) 0.1902
T 3: General parameters among DF and DHF patients.
possibly related to coexisting myositis and released of AST from the injured muscle
cells [12].
In the current study the prolonged PT values presented in 9% of the all cases and
it was significantly more in DF (9.3%). Wong et al and Itha et al reported that the
derangement in PT and PTT in 42.5% and 7% respectively of his cases [13, 20]. While
the deranged PT and PTT in this study was 21.6%. This because that most of our cases
are DF 86.5% unlike the abovementioned studies most of their cases are DHF and DSS.
A correlation between the levels of AST and PTT shows a strong association between
AST elevation and PTT prolonged time in dengue infection in our patients (P< 0.0003),
this might seem to relate to the process of hepatic parenchymal damage than the
biliary tract obstruction.
Parameters Median Mean ± SD Range of test Normal range
CRP 136 mg/l 125 ± 49 4 – 230 5 – 120 mg/l
AST 34 U/l 54 ± 69 5 – 480 Up to 40 U/l
ALT 22 U/l 34 ± 43 2 – 279 Up to 41 U/l
T 4: Laboratory findings of specific parameters among the studied dengue patients.
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Parameters DF n = 81 DHF n = 20 P. value
High CRP 70 (86.4%) 17 (85%) 0.2873
High AST 35 (43.2%) 9 (45%) 0.9785
High ALT 17 (21%) 5 (25%) 0.6171
T 5: Special parameters among DF and DHF patients.
Fulminant hepatic failure may occur because of acute hepatitis andmassive necrosis
of the liver, causing hepatic encephalopathy and even death [21]; this finding was not
diagnosed in our patients.
With regard to CRP, the level was high in DHF patients. Nevertheless, this high
circulating level of CRP is not correlated with the severity of illness and the occurrence
of complications (P< 0.0966). A study by Shiann et al [22] in Taiwan showed that
patients with dengue infection were more likely to have low CRP, which is different
from our results, this difference may be due to the environmental factor and sample
size numbered. In contrast, Juffrie et al [23] reported a high level of CRP in their study
and Kutsuna et al [24] who reported that CRP is useful to indicate the dengue fever;
our findings are consistent with them.
The advantage of this study is that it is prospective and only serological confirmed
positive dengue infected patients were enrolled. The limitation of this study is that
liver biopsy was not performed in any patients to confirm the diagnosis. This study
could be considered a base for the future studies regarding the liver damage.
5. Conclusion
In summary, this study demonstrated that hepatic dysfunction may be attributed to
dengue virus infection which evident by prolongation in PT and PTT as well as hypofib-
rinogenemia and factor deficiencies. The presence of bleeding may be useful in pre-
dicting the extent of liver involvement.
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